Live Breaking News & Updates on Follow On Biologics

Stay updated with breaking news from Follow on biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Infliximab and Biosimilar Yield Similar Results in IBD

New data supported the safety and efficacy of nonmedical switching from infliximab to a biosimilar, according to researchers. ....

United Kingdom , British Columbia , Thomas Tam Hoang , Laura Targownik , University Of Toronto Temerty Faculty Medicine , Centre Of British Columbia , Journal Of The Canadian Association Gastroenterology , Health Canada , University Of British Columbia Faculty Medicine , British Columbia Faculty , Medscape Medical , Canadian Association , Medscape Medical News , Mount Sinai Hospital , Temerty Faculty , Inflammatory Bowel Disease Ibd , Biologic Therapy , Biosimilar Drugs , Follow On Biologics , Board Certification , Oard Recertification , Crohn 039s Disease , Crohn Disease , Egional Enteritis Crohn S , Ulcerative Colitis , Lcerative Colitis Uc ,

For Retina Specialists, 2024 Is a Time to Try New Tools

This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond. ....

United States , West Virginia , Iveric Bio , Abbvie Allergan , Genentech Roche , Pegcetacoplan Syfovre , Reginal Sanders , Samsung Bioepis , David Boyer , Los Angeles , Retina Society , Janssen Pharmaceuticals , American Society Of Retina Specialist , Drug Administration , Eyepoint Pharmaceuticals , Regeneron Pharmaceuticals , American Academy Of Ophthalmology , University Of Illinois Chicago , European Medicines Agency , Alimera Sciences , Apellis Pharmaceuticals , American Society , Retina Specialist , Medscape Medical , Illinois Chicago , Medicare Advantage ,

Biosimilars Have Driven Down Cost of Infliximab

Biosimilars have driven down the costs of originator biologics, but it isn't clear whether those savings are being passed on to patients or increasing access to the drugs. ....

United States , University Of Chicago , Vanderbilt University , Modan Goldman , Davidt Rubin , Samantha Paglinco , Sara Horst , Carle Illinois College Of Medicine , American Gastroenterological Association , Crohn Colitis Foundation , Vanderbilt University Medical Center , Pcrohn Colitis Congress , Colitis Foundation , American Gastroenterological , Carle Illinois College , Merative Marketscan Commercial Claims , Nationwide Children , Biologic Therapy , Biosimilar Drugs , Follow On Biologics , Practice Management , Inflammatory Bowel Disease Ibd , Crohn Amp 039s Disease , Crohn Disease , Egional Enteritis Crohn S ,

Insulin Delivery Device Patents Prolong Market Exclusivity

In a new data analysis, Harvard researchers find that insulin manufacturers have filed multiple patents on delivery devices following the original insulin product approval. ....

United States , Sanofi Lantus , Anders Olsen , Williamb Feldman , Simeoni Taylor , Trademark Office , University Of Maryland , Harvard Medical School , Drug Administration , Us Court , Novo Nordisk , Medscape Medical News , Orange Book , First Circuit , Biologic Therapy , Drug Costs , Biosimilar Drugs , Follow On Biologics , Generic Drug , Eneric Medication , Practice Management , Neuroendocrine Tumor , Washington Dc District Of Columbia , Dherence To Medication Issues For Patients , Expert Testimony , Financial Reimbursement ,

Biosimilars as Effective as Originator Biologics in IBD

In a systematic review, outcomes such as remission and loss of response were similar between patients with IBD who continued their original biologic and those who switched to a biosimilar. ....

United Kingdom , British Columbia , United States , John Marshall , Stephenb Hanauer , Susanna Meade , Northwestern University Feinberg School Of Medicine , Health Canada , Journal Of The Canadian Association Gastroenterology , Canadian Association Of Gastroenterology , University Of British Columbia , Mcmaster University , Canadian Association , Colitis Canada , New Brunswick , Northwestern University Feinberg School , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Biologic Therapy , Biosimilar Drugs , Follow On Biologics ,